{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:04:37Z","timestamp":1792803877545,"version":"4.5.0"},"reference-count":70,"publisher":"Society of Nuclear Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2021,8,1]]},"DOI":"10.2967\/jnumed.120.259689","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T20:45:26Z","timestamp":1627677926000},"page":"1033-1042","source":"Crossref","is-referenced-by-count":122,"title":["Imaging of Pheochromocytoma and Paraganglioma"],"prefix":"10.2967","volume":"62","author":[{"given":"Jorge A.","family":"Carrasquillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank I.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Pryma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2021,7,30]]},"reference":[{"key":"2021090907550748000_62.8.1033.1","unstructured":"Lloyd RV Osamura YR. Kloppel G Rosa J. Who Classification of Tumours of Endocrine Organs. 4th ed. Vol 10. World Health Organization; 2017."},{"key":"2021090907550748000_62.8.1033.2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4158\/EP15725.OR","article-title":"Characteristics and outcomes of metastatic SDHB and sporadic pheochromocytoma\/paraganglioma: an National Institutes of Health study","volume":"22","author":"Turkova","year":"2016","journal-title":"Endocr Pract."},{"key":"2021090907550748000_62.8.1033.3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/jso.24030","article-title":"Phaeochromocytomas and paragangliomas: a difference in disease behaviour and clinical outcomes","volume":"112","author":"Ezzat Abdel-Aziz","year":"2015","journal-title":"J Surg Oncol."},{"key":"2021090907550748000_62.8.1033.4","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2010.153320"},{"key":"2021090907550748000_62.8.1033.5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/er.2017-00062","article-title":"New perspectives on pheochromocytoma and paraganglioma: toward a molecular classification","volume":"38","author":"Crona","year":"2017","journal-title":"Endocr Rev."},{"key":"2021090907550748000_62.8.1033.6","first-page":"349","article-title":"Radiolabeled adrenergic neuron-blocking agents: adrenomedullary imaging with [I-131]iodobenzylguanidine","volume":"21","author":"Wieland","year":"1980","journal-title":"J Nucl Med."},{"key":"2021090907550748000_62.8.1033.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1545-7"},{"key":"2021090907550748000_62.8.1033.8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2042.1999.06310.x"},{"key":"2021090907550748000_62.8.1033.9","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2008.0584"},{"key":"2021090907550748000_62.8.1033.10","first-page":"1599","article-title":"Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas: experience and meta-analysis","volume":"26","author":"Van Der Horst-Schrivers","year":"2006","journal-title":"Anticancer Res."},{"key":"2021090907550748000_62.8.1033.11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1248"},{"key":"2021090907550748000_62.8.1033.12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1054"},{"key":"2021090907550748000_62.8.1033.13","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2751"},{"key":"2021090907550748000_62.8.1033.14","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djs188"},{"key":"2021090907550748000_62.8.1033.15","doi-asserted-by":"publisher","DOI":"10.1007\/s13139-015-0331-7"},{"key":"2021090907550748000_62.8.1033.16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00259-013-2598-1","article-title":"Diagnostic accuracy of 68Ga-DOTANOC PET\/CT imaging in pheochromocytoma","volume":"41","author":"Sharma","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021090907550748000_62.8.1033.17","first-page":"576","article-title":"I-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases","volume":"26","author":"Shapiro","year":"1985","journal-title":"J Nucl Med."},{"key":"2021090907550748000_62.8.1033.18","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.212.1.r99jl3035"},{"key":"2021090907550748000_62.8.1033.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03496.x"},{"key":"2021090907550748000_62.8.1033.20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/1754-9485.12620","article-title":"Genetic status determines 18F-FDG uptake in pheochromocytoma\/paraganglioma","volume":"61","author":"Tiwari","year":"2017","journal-title":"J Med Imaging Radiat Oncol."},{"key":"2021090907550748000_62.8.1033.21","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.058701"},{"key":"2021090907550748000_62.8.1033.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03256.x"},{"key":"2021090907550748000_62.8.1033.23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2352"},{"key":"2021090907550748000_62.8.1033.24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.6297"},{"key":"2021090907550748000_62.8.1033.25","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s00259-019-04398-1","article-title":"European Association of Nuclear Medicine practice guideline\/Society of Nuclear Medicine and Molecular Imaging procedure standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma","volume":"46","author":"Ta\u00efeb","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021090907550748000_62.8.1033.26","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/s00259-017-3728-y","article-title":"Guideline for PET\/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA","volume":"44","author":"Bozkurt","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021090907550748000_62.8.1033.27","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.042721"},{"key":"2021090907550748000_62.8.1033.28","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00259-017-3833-y","article-title":"Quantitative 18F-DOPA PET\/CT in pheochromocytoma: the relationship between tumor secretion and its biochemical phenotype","volume":"45","author":"Amodru","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021090907550748000_62.8.1033.29","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/MNM.0000000000000008","article-title":"Normal biodistribution pattern and physiologic variants of 18F-DOPA PET imaging","volume":"34","author":"Chondrogiannis","year":"2013","journal-title":"Nucl Med Commun."},{"key":"2021090907550748000_62.8.1033.30","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1210\/jc.2017-02324","article-title":"18F-FDOPA PET\/CT imaging of MAX-related pheochromocytoma","volume":"103","author":"Ta\u00efeb","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"key":"2021090907550748000_62.8.1033.31","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-012-2087-y"},{"key":"2021090907550748000_62.8.1033.32","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12126"},{"key":"2021090907550748000_62.8.1033.33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03257.x"},{"key":"2021090907550748000_62.8.1033.34","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1007\/s00259-016-3357-x","article-title":"PET\/CT comparing 68Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT\/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma","volume":"43","author":"Janssen","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021090907550748000_62.8.1033.35","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1498"},{"key":"2021090907550748000_62.8.1033.36","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-009-1297-4"},{"key":"2021090907550748000_62.8.1033.37","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1177\/0284185118764206","article-title":"68Ga-somatostatin receptor analogs and 18F-FDG PET\/CT in the localization of metastatic pheochromocytomas and paragangliomas with germline mutations: a meta-analysis","volume":"59","author":"Kan","year":"2018","journal-title":"Acta Radiol."},{"key":"2021090907550748000_62.8.1033.38","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/SLA.0000000000002671","article-title":"Preoperative 18F-FDG PET\/CT in pheochromocytomas and paragangliomas allows for precision surgery","volume":"269","author":"Nockel","year":"2019","journal-title":"Ann Surg."},{"key":"2021090907550748000_62.8.1033.39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s13139-011-0083-y","article-title":"Role of 18F-FDG PET\/CT, 123I-MIBG SPECT, and CT in restaging patients affected by malignant pheochromocytoma","volume":"45","author":"Cantalamessa","year":"2011","journal-title":"Nucl Med Mol Imaging."},{"key":"2021090907550748000_62.8.1033.40"},{"key":"2021090907550748000_62.8.1033.41","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mednuc.2018.01.003","article-title":"Contribution of 18F-FDG PET\/CT in preoperative evaluation of pheochromocytoma:comparison with MIBG scintigraphy [in French]","volume":"42","author":"Denis","year":"2018","journal-title":"M\u00e9decine Nucl\u00e9aire."},{"key":"2021090907550748000_62.8.1033.42","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-07-0217"},{"key":"2021090907550748000_62.8.1033.43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fonc.2019.00053","article-title":"Clinical, diagnostic, and treatment characteristics of SDHA-related metastatic pheochromocytoma and paraganglioma","volume":"9","author":"Jha","year":"2019","journal-title":"Front Oncol."},{"key":"2021090907550748000_62.8.1033.44","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00259-017-3896-9","article-title":"Superiority of 68Ga-DOTATATE over 18F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx)-related pheochromocytoma and paraganglioma in the pediatric population","volume":"45","author":"Jha","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021090907550748000_62.8.1033.45","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.humpath.2018.11.020","article-title":"Variable somatostatin receptor subtype expression in 151 primary pheochromocytomas and paragangliomas","volume":"86","author":"Leijon","year":"2019","journal-title":"Hum Pathol."},{"key":"2021090907550748000_62.8.1033.46","doi-asserted-by":"publisher","DOI":"10.1210\/jc.74.5.1082"},{"key":"2021090907550748000_62.8.1033.47","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-006-0317-x"},{"key":"2021090907550748000_62.8.1033.48","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.126177"},{"key":"2021090907550748000_62.8.1033.49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/cen.13737","article-title":"Role of DOTATATE-PET\/CT in preoperative assessment of phaeochromocytoma and paragangliomas","volume":"89","author":"Gild","year":"2018","journal-title":"Clin Endocrinol (Oxf)."},{"key":"2021090907550748000_62.8.1033.50","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-015-3268-2"},{"key":"2021090907550748000_62.8.1033.51","doi-asserted-by":"publisher","DOI":"10.1148\/rg.352140164"},{"key":"2021090907550748000_62.8.1033.52","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.161018"},{"key":"2021090907550748000_62.8.1033.53","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.211706"},{"key":"2021090907550748000_62.8.1033.54","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.2.685"},{"key":"2021090907550748000_62.8.1033.55","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.07.2799"},{"key":"2021090907550748000_62.8.1033.56","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0006"},{"key":"2021090907550748000_62.8.1033.57","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2214\/AJR.17.18472","article-title":"Pheochromocytomas versus adenoma: role of venous phase CT enhancement","volume":"210","author":"Mohammed","year":"2018","journal-title":"AJR."},{"key":"2021090907550748000_62.8.1033.58","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2214\/AJR.15.15318","article-title":"Comparison of quantitative MRI and CT washout analysis for differentiation of adrenal pheochromocytoma from adrenal adenoma","volume":"206","author":"Schieda","year":"2016","journal-title":"AJR."},{"key":"2021090907550748000_62.8.1033.59","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/cen.13877","article-title":"Can subunit-specific phenotypes guide surveillance imaging decisions in asymptomatic SDH mutation carriers?","volume":"90","author":"Tufton","year":"2019","journal-title":"Clin Endocrinol (Oxf)."},{"key":"2021090907550748000_62.8.1033.60","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.anorl.2016.10.003","article-title":"Morphological and functional imaging of neck paragangliomas","volume":"134","author":"Guichard","year":"2017","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis."},{"key":"2021090907550748000_62.8.1033.61","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1007\/s00330-015-4024-5","article-title":"The value of a rapid contrast-enhanced angio-MRI protocol in the detection of head and neck paragangliomas in SDHx mutations carriers: a retrospective study on behalf of the PGL.EVA investigators","volume":"26","author":"Gravel","year":"2016","journal-title":"Eur Radiol."},{"key":"2021090907550748000_62.8.1033.62","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0333"},{"key":"2021090907550748000_62.8.1033.63","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-003-1115-3"},{"key":"2021090907550748000_62.8.1033.64","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12239"},{"key":"2021090907550748000_62.8.1033.65","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2830"},{"key":"2021090907550748000_62.8.1033.66","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020152"},{"key":"2021090907550748000_62.8.1033.67","doi-asserted-by":"publisher","DOI":"10.1007\/BF02262730"},{"key":"2021090907550748000_62.8.1033.68","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.surg.2016.05.059","article-title":"Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors","volume":"161","author":"Babic","year":"2017","journal-title":"Surgery."},{"key":"2021090907550748000_62.8.1033.69","doi-asserted-by":"publisher","DOI":"10.1097\/00006231-200607000-00006"},{"key":"2021090907550748000_62.8.1033.70","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.mednuc.2013.02.001","article-title":"Functional assessment of non-metastatic paraganglioma and pheochromocytoma by 18F-FDOPA PET: impact of tumor localization and genetic status [in French]","volume":"37","author":"Cerdan","year":"2013","journal-title":"M\u00e9decine Nucl\u00e9aire."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.120.259689","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T14:56:17Z","timestamp":1631199377000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.120.259689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,30]]},"references-count":70,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,7,30]]},"published-print":{"date-parts":[[2021,8,1]]}},"alternative-id":["10.2967\/jnumed.120.259689"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.120.259689","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,30]]}}}